Zydus Lifesciences board approved a ₹1,100 crore share buyback of up to 0.95% equity at ₹1,150 per share via tender offer.
The buyback size represents 5.16% and 3.84% of standalone and consolidated net worth respectively as of March 31, 2026.
May 29, 2026 is fixed as the record date to determine shareholder eligibility for the buyback.
A buyback committee was formed to execute all necessary actions for the buyback process.